PATENT CLAIM ANALYSIS

Application Number: 16230396
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "243000"]

Abstract:
This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

Claim (Index 33):
The compound of  claim 32 , wherein at least one R x  is heteroarylalkyl, cycloalkylalkyl, or heterocycloalkyl.

Metadata:
- Claim Count in Document: 69.0
- Percentile: 98.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16230412', '16230388', '14690180', '15288878', '15419642']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8147666062917018
- 35 USC 102 Novelty (BERT): 0.5901346506161111
- Combined Prediction Score: 0.7923034107241428
- Mean Citation Score: 431.306696
- Max Citation Score: 552.4783
- Similarity Product: 414.452971440804

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test